KI Webinar Review – How Danaher’s Acquisition of Cepheid Could Shape the Molecular POC Market

KI Webinar Review – How Danaher’s Acquisition of Cepheid Could Shape the Molecular POC Market

Kalorama Information received several questions following its recent webinar regarding the molecular point-of-care (POC) in vitro diagnostics market segment and impact of recent industry M&A activity, especially Danaher’s acquisition of Cepheid. Due to the volume of questions and the time constraint of the webinar’s Q&A session, we were unable to provide live answers to all questions. This blog post addresses several related questions from the webinar and elaborates on another recent post regarding Danaher and Cepheid.


Digital Imaging for Hematology Coming Into Focus

Digital Imaging for Hematology Coming Into Focus

The leader in differential imaging for hematology can expect a more crowded market space in the coming years. CellaVision AB commands an intriguing, peripheral IVD market sub-segment aimed at eliminating one of the most costly and time-consuming procedures: the manual differential. The company’s products effectively replace manual microscopy and cell counting with automated systems that use neural networking and algorithms to classify blood cell populations based on image-captured and archived m...